Literature DB >> 20110444

Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.

Manuel T Silva1.   

Abstract

Emerging data suggest new facets of the concerted participation of neutrophils and macrophages in antimicrobial immunity. The classical view is that DCs and macrophages are the inducers of adaptive antimicrobial immunity, but there is evidence for neutrophil participation in this task as cytokine and chemokine producers and APCs. On the other hand, the concept that the T(H)1 response is only associated with control of infections by intracellular pathogens through activation of macrophages by IFN-gamma, and the T(H)17/IL-17 axis is only involved in protection against extracellular pathogens through mobilization and activation of neutrophils is simplistic: There is evidence suggesting that T(H)1 and T(H)17 responses, separately or in parallel, may use macrophages and neutrophils against infections by extracellular and intracellular microbial pathogens. Opsonization by pathogen-specific Igs enhances the antimicrobial capabilities of neutrophils and macrophages in infections by extracellular and intracellular microbes. The functional partnership between macrophages and neutrophils as inducers and effectors of adaptive antimicrobial immunity conforms to their affiliation with the myeloid phagocyte system and reveals a strategy based on the concurrent use of the two professional phagocytes in the adaptive defense mechanisms. Starting from a common myeloid precursor in the bone marrow, macrophages and neutrophils split during differentiation but come together at the infectious foci for a cooperative strategy that uses modulator and effector activities to attack invading microbial pathogens.

Entities:  

Mesh:

Year:  2010        PMID: 20110444     DOI: 10.1189/jlb.1109767

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  38 in total

Review 1.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

Review 2.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response.

Authors:  Jeongho Park; Jang-Won Lee; Scott C Cooper; Hal E Broxmeyer; Jason R Cannon; Chang H Kim
Journal:  J Leukoc Biol       Date:  2017-07-27       Impact factor: 4.962

Review 4.  Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.

Authors:  Shashikala Bhute; Deepaneeta Sarmah; Aishika Datta; Pallavi Rane; Amit Shard; Avirag Goswami; Anupom Borah; Kiran Kalia; Kunjan R Dave; Pallab Bhattacharya
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-26

Review 5.  Macrophages and neutrophils cooperate in immune responses to Leishmania infection.

Authors:  Alessandra A Filardy; Dayana R Pires; George A DosReis
Journal:  Cell Mol Life Sci       Date:  2011-03-03       Impact factor: 9.261

Review 6.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

Review 7.  Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Tariq A Bhat; Louis Panzica; Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Ann Am Thorac Soc       Date:  2015-11

8.  Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.

Authors:  Elena Zenaro; Enrica Pietronigro; Vittorina Della Bianca; Gennj Piacentino; Laura Marongiu; Simona Budui; Ermanna Turano; Barbara Rossi; Stefano Angiari; Silvia Dusi; Alessio Montresor; Tommaso Carlucci; Sara Nanì; Gabriele Tosadori; Lucia Calciano; Daniele Catalucci; Giorgio Berton; Bruno Bonetti; Gabriela Constantin
Journal:  Nat Med       Date:  2015-07-27       Impact factor: 53.440

9.  Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus.

Authors:  Xiaoliang He; Yunlong Zhang; Ai Zhu; Kang Zeng; Xiuping Zhang; Li Gong; Yusheng Peng; Kuan Lai; Shaogang Qu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

10.  INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.

Authors:  Jinming Yang; Sara Kantrow; Jiqing Sai; Oriana E Hawkins; Mark Boothby; Gregory D Ayers; Eric D Young; Elizabeth G Demicco; Alexander J Lazar; Dina Lev; Ann Richmond
Journal:  Cancer Res       Date:  2012-07-26       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.